[Epidemiology of and risk factors for bladder cancer and for urothelial tumors]
- PMID: 25668830
[Epidemiology of and risk factors for bladder cancer and for urothelial tumors]
Abstract
Bladder cancer is the 5th most commonly diagnosed cancer in France, and most of cases occur in men and patients aged more than 65 years. The incidence and mortality are declining except in women in whom the incidence is increasing in recent years. Urothelial tumors of the upper urinary tract are less common but have similar aetiology to the bladder tumours. The recurrent aspect of superficial tumors and the morbidity of invasive tumors are an economic burden in the Western health systems. The two main risk factors for urothelial tumors are tobacco smoking and occupational exposure to chemicals carcinogens such as polycyclic aromatic hydrocarbons, nitrosamines, aromatic amines and arsenic. Other risk factors include urinary schistosomiasis, pelvic radiation therapy, the use of cyclophosphamide and probably diet and lifestyle factors. Prevention of bladder tumors is based on the control of these risk factors and individual screening in high-risk patients. Recognition as an occupational disease is an important part of the social management of patient, which is today inadequately performed.
Similar articles
-
[Urothelial tumors, occupational diseases].Rev Prat. 2014 Dec;64(10):1375-8. Rev Prat. 2014. PMID: 25665315 French. No abstract available.
-
Epidemiology of urothelial carcinoma.Int J Urol. 2017 Oct;24(10):730-734. doi: 10.1111/iju.13376. Epub 2017 May 21. Int J Urol. 2017. PMID: 28543959 Review.
-
Mechanisms of disease: The epidemiology of bladder cancer.Nat Clin Pract Urol. 2006 Jun;3(6):327-40. doi: 10.1038/ncpuro0510. Nat Clin Pract Urol. 2006. PMID: 16763645 Review.
-
[Influence of occupational exposures in nonmuscle infiltration bladder cancer: preliminary results of a prospective study from October 2005 to February 2009].Prog Urol. 2011 Jun;21(6):405-11. doi: 10.1016/j.purol.2010.11.009. Epub 2011 Jan 26. Prog Urol. 2011. PMID: 21620301 French.
-
[Occupation and tobacco as risk factors in urinary bladder cancer].Hinyokika Kiyo. 1989 Dec;35(12):2041-8. Hinyokika Kiyo. 1989. PMID: 2618903 Japanese.
Cited by
-
Comparison of hyperthermic intravesical chemotherapy using pirarubicin and Bacillus Calmette-Guérin in the treatment of patients with high-risk non-muscle-invasive bladder carcinoma: a retrospective study.BMC Urol. 2025 Apr 9;25(1):81. doi: 10.1186/s12894-025-01773-z. BMC Urol. 2025. PMID: 40205399 Free PMC article.
-
Current and Emerging Treatments for Urothelial Carcinoma: A Focus on Enfortumab Vedotin.Cancer Manag Res. 2023 Jul 18;15:699-706. doi: 10.2147/CMAR.S418009. eCollection 2023. Cancer Manag Res. 2023. PMID: 37485038 Free PMC article. Review.
-
CMTM8 inhibits the carcinogenesis and progression of bladder cancer.Oncol Rep. 2015 Dec;34(6):2853-63. doi: 10.3892/or.2015.4310. Oncol Rep. 2015. PMID: 26503336 Free PMC article.
-
Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma of the Urinary Bladder.Asian Pac J Cancer Prev. 2024 Feb 1;25(2):637-646. doi: 10.31557/APJCP.2024.25.2.637. Asian Pac J Cancer Prev. 2024. PMID: 38415551 Free PMC article.
-
Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy.Transl Androl Urol. 2020 Jun;9(3):1270-1277. doi: 10.21037/tau-19-705. Transl Androl Urol. 2020. PMID: 32676410 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical